EMA Supports New Oral Treatment for PBC Itch
A new oral treatment for the severe itching that often disrupts sleep and quality of life in primary biliary cholangitis (PBC) could soon reach patients, after European regulators backed Lynavoy (linerixibat, GlaxoSmithKline). At its July 2026 meeting, the …